Brief: Ampio Provides Update On Clinical Trials For Ampion Treatment Of Covid-19 Patients
04/01/2021 16:06
Jan 4 (Reuters) - Ampio Pharmaceuticals Inc AMPE.A :
* AMPIO PROVIDES UPDATE ON CLINICAL TRIALS FOR AMPION™
TREATMENT
OF COVID-19 PATIENTS
* AMPIO PHARMACEUTICALS INC - GLOBAL STUDY HAS BEEN
INITIATED IN
ISRAEL AND U.S. WITH FOCUS ON PATIENT SAFETY AND EFFICACY
* AMPIO PHARMACEUTICALS INC - U.S. BASED CLINICAL TRIAL
UNDERWAY
FOR INHALATION TREATMENT OF COVID-19 PATIENTS EXPANDS TO NEW
HOSPITALS
Source text for Eikon: ID:nPn9MzKwfa
Further company coverage: AMPE.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ampio Pharmaceuticals
See all newsBrief: Ampio Announces Voluntary Delisting And SEC Deregistration
Brief: Ampio Provides Update On Results From Pre-IND Enabling Studies
Brief: Ampio Selects Ascendia Pharmaceuticals, Inc. To Provide CDMO Services To Support Clinical Development Of OA-201
Brief: Ampio Pharmaceuticals Announces Reverse Stock Split
Brief: Ampio Pharmaceuticals Inc - Holds Approximately $1.25 Million In A Deposit Account At Silicon Valley Bank